INDV Indivior PLC Quarterly EPS earnings growth

Corporate emblem and logo of Indivior PLC (INDV)

The quarterly EPS evolution is based on the stability of Indivior PLC (INDV) owned plants in the US and UK, which ensures supply reliability. Pricing power derived from patent protection is further complemented by a transition to innovative injections to combat competition. This chart confirms the current fundamental momentum, while 244.70 determines the current value of the indicator.

indivior.com (INDV) Year-over-year earnings per share growth for the last 12 months: for the period 02/21/2024 - 11/12/2026

Summary analytical data breakdowns for Indivior Corp (INDV)

- market value and analyst target forecast:
Price Chart Indivior|INDV - Consensus Target
- market capitalization data:
Market Capitalization Indivior Group|INDV - Company Buyout Price
- balance sheet net asset value indicators:
Net Assets per Single Share Indivior|INDV - Accounting Capitalization|Market Capitalization to Book Value Ratio indivior.com|INDV - Total Business Assets
- debt level and financial liquidity data:
Total Debt to Capital Indivior PLC|INDV - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio Indivior PLC|INDV - Company Debts|Debts to Book Capitalization Indivior Group|INDV - Long-Term Debt Volume|Company Short-Term Debt Indivior|Quick Liquidity indivior.com
- earnings and market multiples details:
INDV - Final Profit|Future Profit Indivior PLC|INDV - Company Value to Net Income|Future Price to Earnings Indivior Group|INDV - Market Cap to Earnings and Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Indivior Group|INDV - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Indivior|INDV - Net earnings per share for the last 12 months|Quarterly EPS earnings growth indivior.com|INDV - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Indivior PLC
Fundamental valuation:Indivior - INDV
Flagship merchandise of indivior.com

This indicator assesses net earnings per share dynamics, reflecting the efficiency of capital generation. By analyzing the quarterly evolution of EPS, an investor can discern management's ability to offset rising operating expenses. The current value of 244.70 is calculated as the percentage change in profit between 10-Q reporting periods. A positive trend confirms the stability of the business's margins. Indivior PLC (INDV) portfolio diversification toward mental health therapies further stabilizes this growth.

Competitors of Indivior PLC (INDV)

Collegium Pharmaceutical, Inc. (COLL) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Cronos Group Inc|CGC (Tweed) - Quarterly EPS earnings growth|Canna Cabana (HITI) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Aurora Cannabis (ACB)|achievelifesciences.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth SKYE (Skye Bioscience, Inc.)|ANEB: Year-over-year earnings per share growth for the last 12 months|Canndoc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Nutriband Inc. NTRB|NSRX (nasuspharma.com) - Year-over-year net earnings per share growth for the last 12 months|IGC (IGC Pharma) - Year-over-year earnings per share growth for the last twelve months|MIRA (MIRA Pharmaceuticals Inc.) - Quarterly EPS earnings growth|Flora Growth Corp (FLGC) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months IM Cannabis Corp. (IMCC)|ADIL - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Artelo Biosciences, Inc. ARTL|Year-over-year earnings per one share growth for the last 12 months ENSC|TTNP: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months GNLN (Greenlane Holdings, Inc.)|InMed Pharma (INM) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months AKAN (Akanda Inc)|Year-over-year earnings per share growth for the last twelve months Enveric Biosciences|Year-over-year earnings per share growth for the last twelve months BGXX|Quarterly EPS earnings growth HPCO